Summary The a6/,B4 integrin complex has been shown to be expressed in murine tissues at the basolateral aspect of most epithelial cells including the mammary epithelium, thus suggesting that this heterodimer may interact with components of the basement membrane. Because transformation of mammary epithelium frequently results in disappearance of basement membranes and loss of cell polarisation we have analysed in the present study whether expression of the a6/P4 complex is altered in human breast tumours. The results of the present study confirm that in human mammary gland a6 and P4 subunits colocalise at the basolateral aspect of the epithelium. While in benign breast lesions this distribution pattern remains mostly unchanged, in primary carcinomas the expression of both chains is either redistributed over the cell surface or significantly reduced. This altered pattern of expression is paralleled by the lack of detection of basement membrane laminin and collagen type IV. In metastatic lesions the expression of the heterodimer is maintained in most of the lymphonodal foci, but less frequently detected in metastasis localised in the pleural cavity and in parenchymal tissues. These findings indicate that in breast epithelium expression of the x6/P4 heterodimer is modulated by the presence of basement membrane and is possibly influenced by microenvironmental factors as suggested by the different pattern of x6/P4 expression in nodal and extranodal metastatic foci.
Integrins represent an expanding family of heterodimeric receptors (Hynes, 1987) involved in cell-to-cell and cell matrix interactions . Accumulating experimental evidence points to a major functional role of integrins in the regulation of cell polarity (Fath et al., 1989) and migration (Hemler, 1990) as well as in morphogenesis (Korhonen et al., 1990) . It has also been proposed that derangement of integrin expression may be responsible for a number of aberrant cell behaviours during tumour onset, progression and metastatic spreading (Plantefaber & Hynes, 1989; Ruoslahti & Giancotti, 1989; Dedhar & Saulnier, 1990; Giancotti & Ruoslahti, 1990) .
In this context the VLA6 (Sonnenberg et al., 1987) integrin which is formed by the non covalent association of a6 and P1
chains is of particular interest since it represents a non promiscuous receptor for the basement membrane glycoprotein laminin (Sonnenberg et al., 1988) . However, the a6 chain can alternatively associate with a different chain to form the a6/,B4 heterodimer (Sonnenberg et al., 1988a; Hemler et al., 1989; Kajiji et al., 1989 ) whose receptorial activity is not yet fully characterised. Detailed immunohistochemical studies of murine tissues (Sonnenberg et al., 1990) have revealed that a6, P4 and P1 codistribute in most epithelia including the mammary epithelium at the basolateral aspect, thus suggesting that o6/P4 dimers physically interact with some basement membrane component/s which may in turn modulate this expression and cellular compartimentalisation (Fath et al., 1989) . The observation that transformation of mammary epithelium is frequently associated with lack of basement membranes (Ozzello, 1979; Natali et al., 1984; Birembaut et al., 1985; Tsubura et al., 1988) provides the opportunity to test this hypothesis through the comparative analysis of o6/P4 expression in normal and transformed primary and metastatic human mammary epithelium. We report here that in human breast tumours the lack of laminin and collagen type IV i.e. basement membranes is associated with a significantly reduced expression of oc6/P4 as well as loss of its polarised pattern of expression.
Materials and methods

Tissues
Surgical biopsies of normal, benign and malignant tumour tissues were collected following ablative surgery from patients free of chemo and radiotherapy. Tissues were snap frozen in liquid nitrogen. From each specimens consecutive 4 cryostat sections were obtained which were fixed in cold absolute acetone for 10 min. Fixed sections were either immediately used in immunohistochemical assay or kept frozen at -3OC with no loss of serological activity. Fixed sections stained with 1% toluidine blue were used to evaluate the histological features of the tissues.
Monoclonal and polyclonal antisera
The murine monoclonal antibody (MoAb) A-1A5 to the P1 subunit (Hemler et al., 1983) was kindly provided by Dr M.E. Hemler (Dana Farber Cancer Inst., Boston Ma., USA). The rat MoAb 135-13C to the a6 (Falcioni et al., 1986) and MoAb 439-9B (Falcioni et al., 1988) to x6 and was, even more pronounced with antibodies to P4 chain. Staining of a6 and P4 at the basal aspect of luminal cells was rarely seen. By indirect immunofluorescence which in our hands allowed a higher resolution, an ordered punctuate stain could be observed for a6 and P4 in section planes running tangential to the basal portion of the ductal and acinar epithelium (Figure la inset) . The extent to which myoepithelial and luminal cells contributed to this pattern could not be firmly established. The staining patterns described above were maintained in three types of benign breast tumours tested (Table I) . Only in two cases of gynecomastia was the plasma-membrane stain for a6 not associated with detectable levels of P4.
Changes in distribution of a6 and P4 subunits in primary and metastatic breast tumours Evaluation of primary breast tumours of the most common histotypes (Table I) indicates that the expression of x6 and P4 subunits undergoes a number of changes. As a general rule, P4 was never expressed in absence of x6. Three major staining patterns were observed. Staining for az6 and P4 in a significant number of tumours was undetectable at the level of the cell membrane (Figure lb) . This was more frequently seen in lobular and infiltrating ductal carcinomas while it was less common in tubular tumours. Moreover polarised stain for both subunits at the periphery of tumour cell nests ( Figure 1c ) was rare in most tumour histotypes. The punctuate stain at the base of tumour cell nests was never observed.
The results of the comparative immunohistochemical evaluation of primary tumours and autologous metastasis as well as of metastasis from various anatomical sites are summarised in Table II . Also in this instance three major staining patterns could be observed since staining for P4 was never observed in the absence of detectable a6 chain. Among metastatic lesions, especially those located in lymph nodes (40%) displayed stain for both subunits on tumour cell membrane (Figure ld) . In only four out of 26 metastases was a polarisation of the stain for both chains seen at the periphery of tumour cell nests. While the distribution of both subunits in primary lesions was often (67%) different from that observed in metastatic foci, the distribution of both chains was rather consistent among multiple concomitant autologous metastases. In one case (patient Br) whilst the primary tumour lacked a6 and P4 stain, both chains were expressed in the lymphonodal autologous lesions. As opposed to nodal lesions, parenchymal and particularly pleural metastasis (ten were also stained by the anti-laminin and collagen type IV antiserum. i.e. tumours possessing an antigenically integer basement membrane. Lack of detectable laminin and collagen type IV in five out of seven cases was associated with negative stain for all of the three integrin subunits.
Discussion
The study of the interaction of cells with extracellular matrix components is instrumental in understanding cell differentiation, tissue morphogenesis and the pathogenetic pathways of tumour growth and metastatic spreading. These areas of study are being increasingly explored since the identification of the superfamily of the integrin molecules which mediate a number of specific ligand-receptor interactions between cells and their surrounding milieu (Hynes, 1987; . Different molecular mechanisms may perturb integrin functions during tumour progression, including qualitative and quantitative changes in integrin expression (Hirst et al., 1986; Plantefaber & Hynes, 1989) as well as loss of integrin ligands, i.e. extracellular matrix components (Ruoslahti & Giancotti, 1989; Giancotti & Ruoslahti, 1990) . Indeed recent immunohistochemical studies have extended to human tumours the earlier observations obtained either in tissue culture systems or in animal (McGregor et al., 1989; Wolf et al., 1990; Natali et al., 1991) . In agreement with others (Koukoulis et al.,1991; Streuli et al., 1991) (Ozzello, 1979; Natali et al., 1984; Birombaut et al., 1985; Tsubura et al., 1988) (Heino et al., 1989) 
